Immune Microenvironment of Muscular-Invasive Urothelial Carcinoma: The Link to Tumor Immune Cycle and Prognosis.
Stakhovskyi O, Kobyliak N, Voylenko O, Stakhovskyi E, Ponomarchuk R, Sulaieva O.
Cells. 2022 May 31;11(11):1802. doi: 10.3390/cells11111802.
PMID:35681497
Single-cell transcriptomic analysis of tumor heterogeneity and intercellular networks in human urothelial carcinoma.
Jin X, Wang Q, Luo F, Pan J, Lu T, Zhao Y, Zhang X, Xiang E, Zhou C, Huang B, Lu G, Chen P, Shao Y.
Chin Med J (Engl). 2023 Mar 20;136(6):690-706. doi: 10.1097/CM9.0000000000002573.
PMID:36939254
New Advances in Metastatic Urothelial Cancer: A Narrative Review on Recent Developments and Future Perspectives.
Tonni E, Oltrecolli M, Pirola M, Tchawa C, Roccabruna S, D'Agostino E, Matranga R, Piombino C, Pipitone S, Baldessari C, Bacchelli F, Dominici M, Sabbatini R, Vitale MG.
Int J Mol Sci. 2024 Sep 7;25(17):9696. doi: 10.3390/ijms25179696.
PMID:39273642
[Tumour-stroma interactions in urothelial cancer].
Hatina J, Kripnerová M, Tuková J, Šrámek J, Dvořák P, Pešta M, Dobrá J, Babuška V, Racek J, Sobol M, Philimonenko A, Hozák P, Czuba Z, Schulz WA, Strell C, Grimm S, Jennek S, Friedrich KH.
Urologe A. 2015 Apr;54(4):516-25. doi: 10.1007/s00120-014-3754-3.